Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial.
Sehgal K, Pappa T, Shin KY, Schiantarelli J, Liu M, Ricker C, Besson NR, Jones SM, Welsh EL, Pfaff KL, Barletta JA, Park J, Reardon B, Doherty GM, Alexander EK, Rodig SJ, Barbie DA, O'Neill A, Van Allen E, Haddad RI, Lorch JH.
Sehgal K, et al.
JAMA Oncol. 2024 Oct 24:e244019. doi: 10.1001/jamaoncol.2024.4019. Online ahead of print.
JAMA Oncol. 2024.
PMID: 39446365